HP
Basic information
Region (hg38): 16:72054505-72061055
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Anhaptoglobinemia; Hypohaptoglobinemia | AR | Hematologic | Variants may be important in specific situations (eg, related to transfusion) | Hematologic | 9463309; 10666182; 14999562 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 11 | |||||
missense | 21 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 22 | 9 | 6 |
Variants in HP
This is a list of pathogenic ClinVar variants found in the HP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-72054562-A-C | Anhaptoglobinemia | Affects (Nov 01, 2003) | ||
16-72056163-C-A | Benign (Jun 01, 2018) | |||
16-72056174-G-C | not specified | Uncertain significance (Mar 14, 2023) | ||
16-72056201-C-A | not specified | Uncertain significance (Oct 31, 2022) | ||
16-72056222-A-G | not specified | Uncertain significance (Sep 12, 2024) | ||
16-72056546-G-GC | Anhaptoglobinemia | Uncertain significance (Mar 18, 2016) | ||
16-72056553-G-A | Benign (May 25, 2018) | |||
16-72057409-G-A | not specified | Likely benign (Mar 23, 2022) | ||
16-72057412-A-G | not specified | Likely benign (Mar 23, 2022) | ||
16-72057415-A-G | HAPTOGLOBIN, ALPHA-1, FAST-SLOW POLYMORPHISM | Benign (Oct 01, 1983) | ||
16-72058266-C-T | not specified | Likely benign (Aug 20, 2024) | ||
16-72059135-A-G | not specified | Uncertain significance (May 18, 2022) | ||
16-72060107-G-A | HP-related disorder | Likely benign (Aug 15, 2019) | ||
16-72060133-C-A | not specified | Uncertain significance (May 23, 2023) | ||
16-72060133-C-G | not specified | Uncertain significance (Nov 15, 2024) | ||
16-72060151-G-A | not specified | Uncertain significance (Sep 11, 2024) | ||
16-72060181-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
16-72060219-A-T | not specified | Uncertain significance (Dec 19, 2023) | ||
16-72060233-T-G | Likely benign (Jan 01, 2023) | |||
16-72060311-G-A | not specified | Likely benign (Sep 05, 2024) | ||
16-72060328-C-T | not specified | Uncertain significance (Dec 18, 2023) | ||
16-72060337-T-C | not specified | Uncertain significance (Jun 16, 2024) | ||
16-72060352-A-C | not specified | Uncertain significance (Aug 13, 2021) | ||
16-72060377-T-G | Likely benign (Jul 11, 2018) | |||
16-72060387-C-A | not specified | Uncertain significance (Dec 20, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HP | protein_coding | protein_coding | ENST00000355906 | 7 | 6464 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000174 | 0.888 | 124771 | 0 | 28 | 124799 | 0.000112 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0135 | 212 | 213 | 0.997 | 0.0000116 | 2650 |
Missense in Polyphen | 60 | 72.772 | 0.82449 | 856 | ||
Synonymous | -0.499 | 89 | 83.2 | 1.07 | 0.00000495 | 770 |
Loss of Function | 1.51 | 10 | 16.7 | 0.600 | 7.98e-7 | 227 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000287 | 0.000287 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000557 | 0.0000557 |
Finnish | 0.0000464 | 0.0000464 |
European (Non-Finnish) | 0.000152 | 0.000150 |
Middle Eastern | 0.0000557 | 0.0000557 |
South Asian | 0.000131 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: As a result of hemolysis, hemoglobin is found to accumulate in the kidney and is secreted in the urine. Haptoglobin captures, and combines with free plasma hemoglobin to allow hepatic recycling of heme iron and to prevent kidney damage. Haptoglobin also acts as an Antimicrobial; Antioxidant, has antibacterial activity and plays a role in modulating many aspects of the acute phase response. Hemoglobin/haptoglobin complexes are rapidely cleared by the macrophage CD163 scavenger receptor expressed on the surface of liver Kupfer cells through an endocytic lysosomal degradation pathway. {ECO:0000269|PubMed:21248165}.;
- Disease
- DISEASE: Anhaptoglobinemia (AHP) [MIM:614081]: A condition characterized by the absence of the serum glycoprotein haptoglobin. Serum levels of haptoglobin vary among normal persons: levels are low in the neonatal period and in the elderly, differ by population, and can be influenced by environmental factors, such as infection. Secondary hypohaptoglobinemia can occur as a consequence of hemolysis, during which haptoglobin binds to free hemoglobin. Congenital haptoglobin deficiency is a risk factor for anaphylactic non-hemolytic transfusion reactions. {ECO:0000269|PubMed:14999562}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Neutrophil degranulation;Vesicle-mediated transport;Innate Immune System;Immune System;Scavenging of heme from plasma;Binding and Uptake of Ligands by Scavenger Receptors
(Consensus)
Recessive Scores
- pRec
- 0.841
Intolerance Scores
- loftool
- 0.235
- rvis_EVS
- -0.8
- rvis_percentile_EVS
- 12.24
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.194
- ghis
- 0.491
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.839
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hp
- Phenotype
- liver/biliary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; neoplasm; immune system phenotype; renal/urinary system phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- acute inflammatory response;proteolysis;receptor-mediated endocytosis;defense response;acute-phase response;response to organic substance;positive regulation of cell death;response to hydrogen peroxide;defense response to bacterium;neutrophil degranulation;negative regulation of oxidoreductase activity;cellular oxidant detoxification;negative regulation of hydrogen peroxide catabolic process
- Cellular component
- extracellular region;extracellular space;haptoglobin-hemoglobin complex;specific granule lumen;extracellular exosome;endocytic vesicle lumen;blood microparticle;tertiary granule lumen
- Molecular function
- serine-type endopeptidase activity;protein binding;antioxidant activity;hemoglobin binding